Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus
Keywords: bioresorbable vascular scaffolds; coronary artery disease; diabetes; BVS; bioresorbable vascular scaffold; CL; confidence limit; DES; drug-eluting stent(s); EES; everolimus-eluting stent; MI; myocardial infarction; PCI; percutaneous coronary intervention;